DOCSLIB.ORG

Osteoclastogenesis: Roles of Filamin a and SBDS, and Their Regulation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Osteoclastogenesis: Roles of Filamin a and SBDS, and Their Regulation Osteoclastogenesis: Roles of Filamin A and SBDS, and their Regulation of Rho GTPases during Pre-Osteoclast Migration by Roland Leung A thesis submitted in conformity with the requirements for the Degree of Doctor of Philosophy Faculty of Dentistry University of Toronto © Copyright by Roland Leung 2012 Library and Archives Bibliothèque et Canada Archives Canada Published Heritage Direction du Branch Patrimoine de l'édition 395 Wellington Street 395, rue Wellington Ottawa ON K1A 0N4 Ottawa ON K1A 0N4 Canada Canada Your file Votre référence ISBN: 978-0-494-79488-3 Our file Notre référence ISBN: 978-0-494-79488-3 NOTICE: AVIS: The author has granted a non- L'auteur a accordé une licence non exclusive exclusive license allowing Library and permettant à la Bibliothèque et Archives Archives Canada to reproduce, Canada de reproduire, publier, archiver, publish, archive, preserve, conserve, sauvegarder, conserver, transmettre au public communicate to the public by par télécommunication ou par l'Internet, prêter, telecommunication or on the Internet, distribuer et vendre des thèses partout dans le loan, distrbute and sell theses monde, à des fins commerciales ou autres, sur worldwide, for commercial or non- support microforme, papier, électronique et/ou commercial purposes, in microform, autres formats. paper, electronic and/or any other formats. The author retains copyright L'auteur conserve la propriété du droit d'auteur ownership and moral rights in this et des droits moraux qui protege cette thèse. Ni thesis. Neither the thesis nor la thèse ni des extraits substantiels de celle-ci substantial extracts from it may be ne doivent être imprimés ou autrement printed or otherwise reproduced reproduits sans son autorisation. without the author's permission. In compliance with the Canadian Conformément à la loi canadienne sur la Privacy Act some supporting forms protection de la vie privée, quelques may have been removed from this formulaires secondaires ont été enlevés de thesis. cette thèse. While these forms may be included Bien que ces formulaires aient inclus dans in the document page count, their la pagination, il n'y aura aucun contenu removal does not represent any loss manquant. of content from the thesis. ii Osteoclastogenesis: Roles of Filamin A and SBDS, and their Regulation of Rho GTPases during Pre-Osteoclast Migration Doctor of Philosophy 2012 Roland Leung Faculty of Dentistry University of Toronto Abstract Osteoclasts are multinucleated, bone resorbing cells that carry out their function using specialized actin-based structures called actin rings and podosomes. Rho GTPases function as molecular switches that regulate the actin cytoskeleton in osteoclasts and many other cell types. Filamin A (FLNa) and SBDS are two proteins that have the potential to interact with both F-actin and Rho GTPases, and thus regulate osteoclast formation, differentiation, or function. We found that in FLNa-null pre-osteoclasts, activation of RhoA, Rac1, and Cdc42 was perturbed, leading to defective pre-osteoclast migration prior to fusion. Ablation of SBDS resulted in the blockage of osteoclast differentiation downstream of RANK and defective RANKL-mediated upregulation of Rac2 that is required for pre-osteoclast migration. Therefore, both FLNa and SBDS are required to coordinate Rho GTPase activation during osteoclastogenesis, in addition to a role for SBDS in osteoclast differentiation downstream of RANK. iii Acknowledgements I would like to take this opportunity to thank my family and friends for supporting me through this long journey. I am indebted to my supervisor and my lab colleagues for guiding me in my research. iv Table of Contents Chapter 1: Literature Review I. Osteoclasts and normal bone physiology…………………………………...……2 a. Origins…………………………………………………………………...……..2 b. Osteoclastogenesis…………………………………………………….……..…3 c. In vitro generation of osteoclasts…………………………………………...…..4 d. M-CSF and RANKL………………………………………………………....…4 e. Other important transcription factors……………………………………..……6 f. Osteoimmunology……………………………………………………………...7 g. NFATc1 – the master regulator of osteoclastogenesis…………………………8 2+ h. Intracellular Ca signalling…………………………………………………….8 i. Genes regulated by NFATc1……………………………………………...……9 j. Pre-osteoclast fusion…………………………………………………………..10 i. DC-STAMP……………………………...……………………………10 ii. Other candidate receptors and enhancers of cell fusion…………........11 k. Bone resorption………………………………………………………………..12 l. Integrin αvβ3……………………………………………………………….….14 m. Actin cytoskeleton and osteoclasts……………………………………………15 i. Podosomes…………………………………………………………….16 ii. Actin Ring………………………………………………………...…...16 iii. Regulation of podosomes and actin ring by phosphoinositide signaling…………………………………………....17 II. Rho GTPases……………………………………………………………………..18 a. Rac, Cdc42, and Rho GTPases…………………………………………..……18 b. Actin filament polymerization and cellular migration…………………….......19 c. Spatio-temporal regulation of Rac/Cdc42/Rho activation…………………….20 d. Rho GTPases and the osteoclast………………………………………………21 e. Post-translational prenylation…………………………………………………22 f. Actin rings, podosomes and Rho GTPases……………………………………22 g. Regulation of osteoclast physiology by Rho GTPases………………………..23 h. Reactive oxygen species and Rho GTPases…………………………………..25 III. Filamin A a. Discovery……………………………………………………………………...25 b. Filamin structure and actin crosslinking………………………………….......26 c. Functions of Filamin A i. Actin cytoskeleton stabilization…………………………………….…27 ii. Cellular migration……………………………………………………..27 iii. Syndromes resulting from FLNa mutations………………………..….28 iv. Filamin A binds actin network regulators………………………..……28 d. Regulation of Filamin………………………………………………………....29 v IV. Shwachman-Diamond syndrome……………………………………….……….29 a. Genetic features……………………………………………………………….30 b. SBDS function i. RNA metabolism and ribosome biogenesis………………………...…31 ii. Cell proliferation and viability…………………………………...……32 iii. Actin dynamics and chemotaxis…………………………………..…..32 c. Skeletal phenotype………………………………………………………..…...33 d. Oral manifestations of SDS…………………………………………………...34 V. Objectives and hypotheses………………………………………..……………..35 Chapter 2: Filamin A regulates monocyte migration through Rho GTPases during osteoclastogenesis…………………………………………………….….37 Chapter 3: Sbds is required for Rac2-mediated monocyte migration and signaling downstream of RANK during osteoclastogenesis………………...…74 Chapter 4: Rho GTPase techniques in osteoclastogenesis…………………………..…….104 Chapter 5: Summary and Conclusions…………………………………………………...122 Chapter 6: References…………………………………………………………………..….129 vi Abbreviations α-MEM α -minimal essential medium ABD Actin binding domain ADAM A disintegrin and metalloprotease Akt Thymoma viral proto-oncogene AP-1 Activator protein-1 BCA Bicinchoninic acid Bcl B-cell leukemia/lymphoma BMC Bone mineral content BMD Bone mineral density BMP Bone morphogenetic protein CA Constitutively-active CaM kinase II Ca2+/calmodulin-dependent protein kinase II DAG Diacylglycerol DAP12 DNAX-activating protein 12 DAPI 4'6,-diamidino-2-phenylinodole DC-STAMP Dendritic cell-specific transmembrane protein DN Dominant-negative DRF Diaphanous-related formin DXA Dual-energy x-ray absorptiometry ECM Extracellular matrix ELISA Enzyme-linked immunosorbent assay ERK Extracellular signal-regulated kinase F-actin Filamentous actin FBE Free-barbed-end FBS Fetal bovine serum FcRγ Fc receptor common γ subunit FITC Fluorescein isothiocyanate FLN Filamin fMLP Formyl-methionyl-leucyl-phenylalanine FOV Field of view FPP Farnesyl diphosphate FSD Functional secretory domain G-actin Globular actin GAP GTPase activating protein GDI Guanine nucleotide dissociation inhibitor GDP Guanosine diphosphate GEF Guanine nucleotide exchange factor GGPP Geranylgeranyl diphosphate GGTase Geranylgeranyl transferase vii GM-CSF Granulocygte-macrophage colony stimulating factor GST Glutathione S-transferase GTP Guanosine triphosphate HRP Horse radish peroxidase IFN Interferon Ig Immunoglobulin IL Interleukin IP3 Inositol-1,4,5-trisphosphate IPTG Isopropyl-beta-D-1-thiogalactopyranoside ITAM Immunoreceptor tyrosine-based activation motif JNK c-jun N-terminal kinase LIMK LIM kinase M-CSF Macrophage colony stimulating factor MFR Macrophage fusion receptor MITF Micro-ophthalmia-associated transcription factor MMP Matrix metalloproteinase N-BP Nitrogen-containing bisphosphonate NFATc1 Nuclear factor of activated T cell, cytoplasmic 1 NFκB Nuclear Factor kappa B OCG Osteoclastogenesis ODF Osteoclast differentiation factor OG Octyl-glucoside OPG Osteoprotegerin OPGL Osteoprotegerin ligand OSCAR Osteoclast-associated receptor PAK p21-activated kinase PAMPs Pathogen-associated molecular patterns PBS Phosphate-buffered saline PCR Polymerase chain reaction PFA Paraformaldehyde PI(3,4,5)P3 Phosphatidylinositol 3,4,5 trisphosphate PI(4,5)P2 Phosphatidylinositol 4,5 bisphosphate PI3-K Phosphatidylinositol 3-kinase PI4P-5K Phosphatidylinositol 4-phosphate 5-kinase PKA Protein kinase A PLC Phospholipase C PMSF Phenylmethylsulfonyl fluoride PPAR Peroxisome proliferator-activated receptor PTH Parathyroid hormone PVNH Periventricular nodular heterotopia viii qRT-PCR Quantitative real-time polymerase chain reaction RANK Receptor Activator of Nuclear Factor kappa B RANKL Receptor Activator of Nuclear Factor kappa B ligand RGD Arg-Gly-Asp ROCK Rho kinase ROS Reactive oxygen species SBDS Shwachman-Bodian-Diamond syndrome SDF-1 Stromal cell-derived factor-1 SDS Shwachman-Diamond syndrome SDS-PAGE Sodium dodecyl sulphate-polyacrylamide gel electrophoresis TGF Transforming growth factor
Load more

Recommended publications
  • The Promise of a Cure: 20 Years and Counting
    NEWSFOCUS All grown up. Danny Bessette, a 24-year-old with CF, was 4 years old when he appeared on the cover of Science announcing the discovery of the CF gene. after signing up with Collins, in the spring of 1989. In collaboration with a large research group in Toronto, Canada, that had started an aggressive chase for the CF gene years earlier, the team cloned the CF gene— called the cystic fibrosis transmembrane conductance regulator (CFTR)—and nailed a crucial, disease-causing mutation (Science, 8 September 1989, pp. 1059, 1066, 1073). Everyone in the CF community recalls the electric moment when they heard the news. “I remember seeing it roll off the fax machine, gathering people in the lab, and thinking, ‘What did we need to know’ ” now? says Michael Welsh, a pulmonary physician at the University of Iowa, Iowa City. Most believed that the disease had grown vastly less complex overnight and would soon be eliminated, probably by gene therapy. The Promise of a Cure: on June 19, 2009 On the 20th anniversary of the identifica- tion of the CF gene, as new gene discoveries 20 Years and Counting pile up weekly and hype over the power of genes to transform medicine flows fast, CF The discovery of the cystic fibrosis gene brought big hopes for offers an object lesson in how difficult it is, and how long it takes, to convert genetic gene-based medicine; although a lot has been achieved over 2 decades, knowledge into treatments. Every CF expert the payoff remains just around the corner agrees that the gene discovery transformed their understanding of the disease’s pathol- www.sciencemag.org The gene hunt began quietly, with few the- which sticky mucus accumulates in the ogy.
    [Show full text]
  • Curriculum Vitae Lei Sun (Last Updated May 24, 2018)
    Curriculum Vitae Lei Sun (Last updated May 24, 2018) Department of Statistical Sciences 100 St. George Street Faculty of Arts and Science Toronto, ON M5S 3G3, Canada Division of Biostatistics P: (416) 978-4327, F: (416) 978-5133 Dalla Lana School of Public Health [email protected] University of Toronto http://www.utstat.toronto.edu/sun Degrees 08/2001 Ph.D. Statistics, University of Chicago, USA Two statistical problems in human genetics: I. Detection of pedigree errors; II. Identification of polymorphisms that explain a linkage result Supervisor: Mary Sara McPeek 07/1995 B.S. Mathematics, Fudan University, Shanghai, China Academic Positions 07/2014-present Full Professor Department of Statistical Sciences Faculty of Arts and Science Division of Biostatistics Dalla Lana School of Public Health University of Toronto (75% FTE in Statistics and 25% in Biostatistics) 07/2007-06/2014 Associate Professor Division of Biostatistics Dalla Lana School of Public Health University of Toronto 07/2005-06/2014 Adjunct Professor Department of Statistical Sciences Faculty of Arts and Science University of Toronto 09/2001-06/2007 Assistant Professor Division of Biostatistics Dalla Lana School of Public Health University of Toronto Interruptions/Delays 01/2007-08/2007 Maternity Leave (30 weeks) 04/2004-11/2004 Maternity Leave (30 weeks) 1 Awards 2018 NSERC Discovery Accelerator Supplements (DAS) Program Award, provides substantial and timely additional resources to accelerate progress and maximize the impact of superior research programs 2017 CRM-SSC
    [Show full text]
  • Approach Alone for Prenatal Diagnosis (Adding Microvil
    Letters to the Editor 395 pregnancies would result in the identification, each year, is known about the mutant protein, the range of muta- of about 300,000 couples in which one or both part- tions possible, and the new mutation rate before popu- ners is a likely CF carrier. Who will be responsible for lation screening to identify CF carriers is attempted. counseling couples in advance of the testing, and who It is also necessary that the questions raised by the pos- will interpret the results and discuss further testing op- sibility of general population screening for any genetic tions for such couples? Does one limit counseling post- disorder- including plans for the delivery of counsel- testing to couples in which both partners are identified ing, guidelines for counseling, quality control for test- as carriers of the defined mutation, or should all cou- ing, levels of reimbursement for testing, and medical ples in which one partner is identified as a likely carrier liability- be discussed in the genetics community be- be offered amniocentesis for microvillar enzyme analy- fore that possibility becomes a reality. sis (an approach to CF prenatal diagnosis with its own FRED GILBERT false-positive and false-negative rates [Mulivor et al. Genetics 1987]). Is it sufficient to screen couples for the pres- Cornell University Medical College ence/absence of the defined mutation, or should the New York study be extended to include probes for closely linked markers? Given that only some 70% of CF chromo- somes are identifiable by assaying for the defined mu- References tation (Kerem et al.
    [Show full text]
  • CURRICULUM VITAE February 2019 NAME TSUI, Lap-Chee POSTAL
    CURRICULUM VITAE February 2019 NAME TSUI, Lap-Chee POSTAL ADDRESS Victor and William Fung Foundation 33/F Alexandra House 18 Chater Road Central Hong Kong SAR China E-MAIL ADDRESS [email protected] PERSONAL DATA Date of Birth: 21 December 1950 Place of Birth: Shanghai, China Sex: Male Marital Status: Married (2 children) Citizenship: Canadian EDUCATION BSc (Biology, 1972) The Chinese University of Hong Kong MPhil (Biology, 1974) The Chinese University of Hong Kong PhD (Biological Sciences, 1979) University of Pittsburgh POSTGRADUATE TRAINING 1972-1974 Graduate Student, Department of Biology, New Asia College, The Chinese University of Hong Kong (Supervisor: Dr KK Mark) 1974-1979 Graduate Student, Department of Biological Sciences, University of Pittsburgh (Supervisor: Dr Roger W Hendrix) 1979-1980 Postdoctoral Investigator, Biology Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee (Supervisor: Dr Wen K Yang) 1981-1983 Postdoctoral Fellow, Department of Genetics, The Hospital for Sick Children, Toronto, Ontario (Supervisor: Dr Manuel Buchwald) CURRENT POSITIONS President, Victor and William Fung Foundation, Hong Kong (from August 2014) Director, Qiushi Academy of Advanced Studies, Zhejiang University, Hangzhou (from August 2014) Master, Residential College, Haining International Campus, Zhejiang University (from September 2016) President, The Academy of Sciences of Hong Kong (from November 2015) Emeritus University Professor, University of Toronto (from 2006) Adjunct Scientist, Research Institute, The Hospital for Sick Children,
    [Show full text]
  • Cystic Fibrosis [1]
    Published on The Embryo Project Encyclopedia (https://embryo.asu.edu) Cystic Fibrosis [1] By: Winikates, Kristina Keywords: Genetics [2] Diseases [3] Cystic fibrosis (CF) is a fatal, inherited disease found in humans [4] and characterized by buildup of thick, sticky mucus, particularly in the respiratory and digestive tracts. The abnormally thick mucus prevents the pancreas from functioning normally; it often leads to digestive problems and chronic lung infections. Cystic fibrosis is most prevalent in Caucasian individuals, and approximately 1 in every 29 individuals in the US is a carrier for the mutated CF gene. There are an estimated 30,000 reported cystic fibrosis [5] cases in the US, and 70,000 reported cases worldwide, although the international number is undoubtedly low due to underreporting or early deaths. Unlike disorders such as Down Syndrome and Fetal Alcohol Syndrome [6], CF does not cause characteristic visible abnormalities. However, infants born with CF typically have a low birth weight, are sick, and may be diagnosed with failure to thrive. Abnormally thick and sticky mucus buildup, particularly in the respiratory tract, causes chronic lung infections that can lead to life-threatening illness. The buildup of mucus in the lungs often causes persistent coughing, wheezing, and shortness of breath. The mucus may also obstruct the pancreas, hindering the body’s ability to break down food and absorb nutrients. When the pancreatic ducts are blocked, the individual may grow abnormally slowly and fail to gain weight, despite having a good appetite. Males with CF are usually sterile. While there is no cure for the disease, scientific research has made it possible to detect the disease in the early stages of development when treatments can alleviate certain symptoms.
    [Show full text]
  • Antounians Lina 201511 Msc
    An Inter-Vascular Bed and Inter-Species Investigation of Epigenetic Regulatory Elements in Endothelial Cells by Lina Antounians A thesis submitted in conformity with the requirements for the degree of Master’s of Science Department of Molecular Genetics University of Toronto © Copyright by Lina Antounians 2015 An Inter-Vascular Bed and Inter-Species Investigation of Epigenetic Regulatory Elements in Endothelial Cells Lina Antounians Master’s of Science Molecular Genetics, University of Toronto, 2015 Abstract A major challenge in human genetics is to understand the mechanisms that control gene expression. To identify gene regulatory regions required for vascular homeostasis, we performed chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) for a variety of histone modifications and the JUN transcription factor in primary aortic endothelial cells (ECs) isolated from human, rat (Rattus norvegicus) and bovine (Bos taurus). We generated a chromatin state map for human aortic ECs and found that the vast majority of regulatory regions in aortic ECs were also active in venous ECs. By comparing the genomic occupancy of JUN and a histone modification indicative of active enhancers (H3K27ac) between species, we identified a set of conserved regulatory regions that were enriched for EC-specific pathways and human regulatory disease variants. Overall, we demonstrate that comparative epigenomics is a viable strategy to identify functionally important vascular gene regulatory elements. ii Acknowledgements I would like to express my sincere gratitude to my supervisor Dr. Michael Wilson for his mentorship and encouragement throughout my Master’s degree. I have learned many technical and analytical skills in your lab, but none as important as the passion for learning, teaching, and collaborating with my peers.
    [Show full text]
  • NIH Public Access Author Manuscript Pediatr Pulmonol
    NIH Public Access Author Manuscript Pediatr Pulmonol. Author manuscript; available in PMC 2012 September 1. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Pediatr Pulmonol. 2011 September ; 46(9): 857±869. doi:10.1002/ppul.21456. A Novel Lung Disease Phenotype Adjusted for Mortality Attrition for Cystic Fibrosis Genetic Modifier Studies Chelsea Taylor1,2, Clayton W. Commander3, Joseph M. Collaco4, Lisa J. Strug1,2, Weili Li1,2, Fred A. Wright5, Aaron D. Webel3, Rhonda G. Pace3, Jaclyn R. Stonebraker3, Kathleen Naughton6, Ruslan Dorfman7, Andrew Sandford8, Scott M. Blackman9, Yves Berthiaume10, Peter Paré8, Mitchell L. Drumm11, Julian Zielenski7, Peter Durie12, Garry R. Cutting6, Michael R. Knowles3, and Mary Corey1,2 1Child Health Evaluative Sciences Program, Hospital for Sick Children, Toronto, ON, Canada 2Dalla Lana School of Public Health, University of Toronto, ON, Canada 3Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States 4Eudowood Division of Pediatric Respiratory Medicine, Johns Hopkins University, Baltimore, MD, United States 5Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States 6Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States 7Program in Genetics and Genome Biology, Hospital for Sick Children, Toronto, ON, Canada 8The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University
    [Show full text]
  • Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene [1]
    Published on The Embryo Project Encyclopedia (https://embryo.asu.edu) Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene [1] By: Winikates, Kristina Keywords: Congenital disorders [2] Human development [3] The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene was identified in 1989 by geneticist Lap-Chee Tsui and his research team as the gene associated with cystic fibrosis [4] (CF). Tsui’s research pinpointed the gene, some mutations to which cause CF, and it revealed the underlying disease mechanism. The CFTR gene encodes a protein in cell membranes in epithelial tissues and affects multiple organ systems in the human body. Mutations in the CFTR gene cause dysfunctional regulation [5] of cell electrolytes and water content. Research on the CFTR mutation has shed light on the ways in which this gene is vital to normal human development. Cystic fibrosis is an autosomal recessive disease, meaning it is inherited when a child receives one mutated copy of the CFTR gene from each parent. If individuals have only one defective copy of the gene, they still expresses enough normal copies of the gene to be healthy. Individuals who have two mutated CFTR genes [6] cannot regulate their electrolytes properly and will develop CF. As carriers of the mutated CFTR gene appear to be healthy, the mutated CFTR gene may remain undetected without prenatal or genetic screening. The CFTR gene belongs to a family of genes [6] that regulate the energy transfer that allows a cell to open and close its ion channels. It is located on human chromosome 7 [7] and consists of twenty-seven sequences of DNA that encode 1,480 amino acids.
    [Show full text]
  • Summary of Congress Abstracts
    Summary of Congress Abstracts Session 1. Clinical Features Discussion Leader: Kimberly Smith Whitley, MD, Children’s Hospital of Philadelphia, PA Gastrointestinal Features of Shwachman-Diamond Syndrome Peter R Durie, MD FRCPC, Hospital for Sick Children and University of Toronto, Canada Most people with Shwachman Diamond syndrome (SDS) first have symptoms in infancy from pancreatic failure. This included fatty bulky bowel motions, malnutrition and growth failure. Some patients have severe feeding problems while others have a voracious appetite. With the exception of infants and children with feeding difficulties, malnutrition is rarely a long-term problem, provided appropriate treatment with enzyme and vitamin supplements is introduced. It is important to know that in about 50 % of people with SDS the function of pancreas can improve with age, such that digestion of fat and protein can become normal. This usually happens in within the first 4 to 5 years of life. Therefore, it is important to monitor the pancreas closely because those individuals who show enough improvement may be able to discontinue enzymes. Being short is part of having SDS. Newborns with SDS exhibit a moderate deficiency in both height and weight. While SDS patients are generally shorter than average, they are expected to grow at a normal rate. There is no difference in stature between patients with pancreatic insufficiency and those with pancreatic sufficiency. Therefore, poor digestions and the need for enzyme replacement therapy does not account for short stature. Many infants with SDS have an enlarged liver but the liver size tends to normalize with advancing age. Biochemical tests of the liver also show some mild changes but these tend to improve as well.
    [Show full text]
  • Congress Program & Abstract Book
    Congress Program & Abstract Book April 8-11, 2018 Texas Medical Center Houston, Texas Chairpersons Dr. Tarek Elghetany and Dr. Alison Bertuch CONTENTS Page Chairpersons’ Welcome ...................................................................................................................... 03 Sponsors ............................................................................................................................................. 04 CommiƩ ees ........................................................................................................................................ 07 Program .............................................................................................................................................. 09 Speaker Biographies ........................................................................................................................... 13 Speaker Abstracts ............................................................................................................................... 22 Research Abstracts ............................................................................................................................. 45 2 Congress Chairpersons’ Welcome Dear Friends and Colleagues, We are honored and humbled by the opportunity to host the 9th International Congress on Shwachman- Diamond syndrome (SDS) in Houston, Texas. In addition to being known as the fourth largest city in the USA and hub for the energy and space exploration industries, Houston is known for the Texas Medical
    [Show full text]
  • Consensus Guidelines for Diagnosis and Treatment of Shwachman-Diamond Syndrome
    Ann. N.Y. Acad. Sci. ISSN 0077-8923 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES Issue: Annals Meeting Reports Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome Yigal Dror,1 Jean Donadieu,2 Jutta Koglmeier,3 John Dodge,4 Sanna Toiviainen-Salo,5 Outi Makitie,5 Elizabeth Kerr,1 Cornelia Zeidler,6 Akiko Shimamura,7 Neil Shah,3 Marco Cipolli,8 Taco Kuijpers,9 Peter Durie,1 Johanna Rommens,1 Liesbeth Siderius,10 and Johnson M. Liu11 1The Hospital For Sick Children, University of Toronto, Ontario, Canada. 2Trousseau Hospital, Paris, France. 3Great Ormond Street Hospital and Institute of Child Health, London, UK. 4University of Wales Swansea, UK. 5Helsinki University Hospital and Children’s Hospital, University of Helsinki, Helsinki, Finland. 6Hannover Medical School, Hannover, Germany. 7Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington. 8Cystic Fibrosis Center, Ospedale Civile Maggiore, Verona, Italy. 9Emma Children’s Hospital, Academic Medical Center, University of Amsterdam, the Netherlands. 10Youth Health Care, Meppel, the Netherlands. 11The Feinstein Institute for Medical Research, Cohen Children’s Medical Center of NY, Manhasset and New Hyde Park, NY Address for correspondence: Johnson M. Liu, MD, The Feinstein Institute for Medical Research, Cohen Children’s Medical Center of NY, Room 255, New Hyde Park, NY 11040, [email protected] Shwachman-Diamond syndrome (SDS) is an autosomal recessive disorder characterized by pancreatic exocrine insuf- ficiency and bone marrow failure, often associated with neurodevelopmental and skeletal abnormalities. Mutations in the SBDS gene have been shown to cause SDS. The purpose of this document is to provide draft guidelines for diagnosis, evaluation of organ and system abnormalities, and treatment of hematologic, pancreatic, dietary, dental, skeletal, and neurodevelopmental complications.
    [Show full text]
  • CURRICULUM VITAE March 2016 NAME TSUI, Lap-Chee POSTAL
    CURRICULUM VITAE March 2016 NAME TSUI, Lap-Chee POSTAL ADDRESS Victor and William Fung Foundation 33/F Alexandra House 18 Chater Road Central Hong Kong SAR China E-MAIL ADDRESS [email protected] PERSONAL DATA Date of Birth: 21 December 1950 Place of Birth: Shanghai, China Sex: Male Marital Status: Married (2 children) Citizenship: Canadian CURRENT POSITIONS President, Victor and William Fung Foundation, Hong Kong (from August 2014) Director, Qiushi Academy of Advanced Studies, Zhejiang University, Hangzhou (from August 2014) President, The Academy of Sciences of Hong Kong (from November 2015) Emeritus University Professor, University of Toronto (from 2006) Adjunct Scientist, Research Institute, The Hospital for Sick Children, Toronto (from 2006) Justice of the Peace, Hong Kong SAR Government (from July 2006) ADVISORY BOARDS and COMMITTEES (current) Advisor, China Association (HK) for Science and Society, 2003 – Member of Advisory Council, National Yang Ming University, Taiwan, 2007 – Chair, International Scientific Advisory Board, Philippine Genome Center, 2011 – Member, Gordon Research Conference, Hong Kong Advisory Board, 2012 – Mentor, Morningside Cultural China Scholars Program, Zhejiang University, August 2012 – Member, International Academic Advisory Committee, Peter Wall Institute for Advanced Studies, University of British Columbia, 2012 – Member, Selection Board, Canada Excellence Research Chairs, 2012 – Member, Board of Governors, Lui Chi Woo Prize Limited, Hong Kong, 2013 – Member, the International Council on Global Competitiveness
    [Show full text]